{"id":"W4409541253","doi":"10.1111/ajd.14468","title":"Development of an Australasian Dermatology Registry","year":2025,"lang":"en","type":"article","venue":"Australasian Journal of Dermatology","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eli Lilly Australia; LEO Pharma; UCB Pharma; Valeant Pharmaceuticals International; Argenx; Pfizer; Incyte; Sun Pharma; Dermira; Genentech; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Johnson and Johnson; AbbVie; Sanofi; Celgene; Novartis; GlaxoSmithKline; Boehringer Ingelheim; Amgen; Galderma; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Dermatology; Quality of life (healthcare); Burden of disease; Disease; Patient registry; Disease registry; Disease burden; Intensive care medicine; Pediatrics; Pathology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001379007,0.000235703,0.001027129,0.0005755143,0.00007926775,0.00001467466,0.0003476068,0.0003311004,0.0001410858],"category_scores_gemma":[0.0001019166,0.0002053084,0.0002042175,0.0003290331,0.0003210105,0.0001837221,0.00004271442,0.0004800178,0.00001049853],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004935261,"about_ca_system_score_gemma":0.0009668857,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000003432252,"about_ca_topic_score_gemma":0.00002007684,"domain_scores_codex":[0.9976037,0.0001060451,0.001423976,0.0002111042,0.0002428275,0.0004123804],"domain_scores_gemma":[0.9984186,0.00005214224,0.0006164896,0.0003726005,0.0002834647,0.0002567021],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"case_report","study_design_scores_codex":[0.001809503,0.004307308,0.7814029,0.003509653,0.003596868,0.02664021,0.006892144,0.00002130123,0.03279876,0.02660879,0.02732124,0.08509129],"study_design_scores_gemma":[0.01290367,0.0009509396,0.3550673,0.001684948,0.001036093,0.3737433,0.01063091,0.00007033473,0.140133,0.00481018,0.0982182,0.0007510246],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9824827,0.0003088446,0.0005240477,0.01014965,0.0003787971,0.0001559738,0.000002202063,0.00001950354,0.005978235],"genre_scores_gemma":[0.9804431,0.00002896109,0.01864336,0.0002289952,0.00002996172,0.000003091168,0.000009408164,0.00001648741,0.0005966492],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4263356,"threshold_uncertainty_score":0.8372234,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01547439367408705,"score_gpt":0.3008742296212409,"score_spread":0.2853998359471538,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}